Literature DB >> 9666274

Cannabinoid receptors and the cytokine network.

T W Klein1, C Newton, H Friedman.   

Abstract

Splenocyte cultures from BALB/c mice were treated with THC and mitogen and shown to produce less Th1 cytokine, IFN gamma, and more Th2 cytokines, IL-4 and IL-10. This suggested that drug treatment caused a shift in the development of Th1 and Th2 cells. In studies designed to look at molecular mechanisms, the CBI antagonist, SR141716A, did not attenuate the THC enhancement of IL-4 production, but pertussis toxin attenuated the drug effect and the CB2 agonist, JWH-051, increased IL-4 production similar to THC. These results suggest that cannabinoids may increase Th2 development and IL-4 production in cultured immune cells through the activity of the CB2 receptor subtype. Studies are currently in progress to further define the molecular and cellular mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666274     DOI: 10.1007/978-1-4615-5347-2_24

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Palmitoylethanolamide regulates development of intestinal radiation injury in a mast cell-dependent manner.

Authors:  Junru Wang; Junying Zheng; Ashwini Kulkarni; Wen Wang; Sarita Garg; Paul L Prather; Martin Hauer-Jensen
Journal:  Dig Dis Sci       Date:  2014-05-22       Impact factor: 3.199

Review 2.  Emerging therapeutic targets of sepsis-associated acute kidney injury.

Authors:  Sundararaman Swaminathan; Mitchell H Rosner; Mark D Okusa
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

3.  Mouse T cells express a neurotransmitter-receptor signature that is quantitatively modulated in a subset- and activation-dependent manner.

Authors:  Kenneth M Rosenberg; Nevil J Singh
Journal:  Brain Behav Immun       Date:  2019-04-03       Impact factor: 7.217

4.  Cat odour-induced anxiety--a study of the involvement of the endocannabinoid system.

Authors:  Silva Sütt; Sirli Raud; Tarmo Areda; Ain Reimets; Sulev Kõks; Eero Vasar
Journal:  Psychopharmacology (Berl)       Date:  2007-09-20       Impact factor: 4.530

Review 5.  Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).

Authors:  Hester van Diepen; Eberhard Schlicker; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-25       Impact factor: 3.000

6.  Sch35966 is a potent, selective agonist at the peripheral cannabinoid receptor (CB2) in rodents and primates.

Authors:  W Gonsiorek; C A Lunn; X Fan; G Deno; J Kozlowski; R W Hipkin
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

7.  The cannabinoid receptor 2 is critical for the host response to sepsis.

Authors:  Johannes Tschöp; Kevin R Kasten; Ruben Nogueiras; Holly S Goetzman; Cynthia M Cave; Lisa G England; Jonathan Dattilo; Alex B Lentsch; Matthias H Tschöp; Charles C Caldwell
Journal:  J Immunol       Date:  2009-06-12       Impact factor: 5.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.